9
May
2018

Charting His Own Entrepreneurial Course: Ethan Perlstein on The Long Run

Please subscribe and tell your friends why it’s worthwhile. Quality journalism costs money. When you subscribe to Timmerman Report at $169 per year, you reward quality independent biotech reporting, and encourage more.

 
 

You may also like

The Final Frontier of Brain Science: Nancy Stagliano on The Long Run
Leading the Fight Against Infectious Disease: Diana Brainard on The Long Run
Investing in the Future of Medicine: Reid Huber on The Long Run
Catching Cancer Early, Investing in Data and AI: Jeff Huber on The Long Run